TenNor Therapeutics (Suzhou) Ltd — Form D

TenNor Therapeutics (Suzhou) Ltd of SUZHOU, F4, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-26. The offering totals $14.7M, of which $14.7M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-05-26
• Form: D
• Accession: 0001104659-26-066134
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $14.7M
• Amount sold: $14.7M
• Investors: 1
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-585070

Issuer

• Name: TenNor Therapeutics (Suzhou) Ltd
• CIK: 0002136090
• Entity type: Corporation
• Jurisdiction: CHINA
• Address: UNIT 701, BLOCK B7, BIOBAY 218 XINGHU STREET, SUZHOU, F4, 215123
• Phone: 008651286861990

Officers, directors & promoters (11)

More

• CIK 2136090 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search